Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptors

This publication has 14 references indexed in Scilit:

• Cathepsin D assay in primary breast cancer and lymph nodes: Relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness
  European Journal of Cancer and Clinical Oncology, 1990
• 3. Role of theINT-genes in murine mammary tumor development and implications for human breast cancer
  International Journal of Cancer, 1990
• Chapter III. 1. Mutations in human breast cancer cells: Dominantly-acting oncogenes and tumor suppressor genes suggest strategies for targeted interference
  International Journal of Cancer, 1990
• c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma
  British Journal of Cancer, 1989
• A paradigm for oncogene complementation in human breast cancer
  Research in Virology, 1989
• In Vivo Amplification and Rearrangement of c-myc Oncogene in Human Breast Tumors
  JNCI Journal of the National Cancer Institute, 1988
• Int‐1 and int‐2: Oncogenic proteins, mitogens and morphogens?
  BioEssays, 1988
• Potential oncogene product related to growth factors
  Nature, 1987
• The neu Gene: an erb B-Homologous Gene Distinct from and Unlinked to the Gene Encoding the EGF Receptor
  Science, 1985
• Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
  Nature, 1984